Axa S.A. Siga Technologies Inc Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$4.93 - $5.8 $290,332 - $341,567	-58,891 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$5.22 - $6.1 $153,990 - $179,950	-29,500 Reduced 33.37%	58,891 $335,000
Q1 2019 May 14, 2019	BUY	$5.66 - $7.89 $375,773 - $523,824	66,391 Added 301.78%	88,391 $531,000
Q4 2018 Feb 13, 2019	BUY	$4.77 - $7.9 $104,939 - $173,800	22,000 New	22,000 $174,000

184

35.6M

873K

466K

Ticker SIGA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 73,024,096
Market Cap $434M
Description
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.